|
⚲
|
| Keyboard |
| French Glendon E III
✚
|
|
|---|---|
| CIK # | 0001805624 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001805624] | |
| 4 | [0001805624] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Pulmonx Corp | |
| French Glendon E III | |
| EDAP TMS Sa |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Pulmonx Corp LUNG
Common Stock
|
2026-03-02 | Sell | 6,737 | $1.43 | 9,634 |
|
Pulmonx Corp LUNG
Common Stock
|
2026-03-02 | Sell | 58,368 | $1.43 | 83,466 |
|
Pulmonx Corp LUNG
Common Stock
|
2026-03-02 | Sell | 2,708 | $1.43 | 3,872 |
|
Pulmonx Corp LUNG
Common Stock
|
2025-12-01 | Sell | 6,281 | $1.57 | 9,861 |
|
Pulmonx Corp LUNG
Performance Stock Units · derivative
|
2025-12-01 | Grant | 800,000 | $0.00 | |
|
Pulmonx Corp LUNG
Common Stock
|
2025-12-01 | Sell | 2,524 | $1.57 | 3,963 |
|
Pulmonx Corp LUNG
Common Stock
|
2025-12-01 | Grant | 1,200,000 | $0.00 | |
|
Pulmonx Corp LUNG
Common Stock
|
2025-06-02 | Grant | 37,153 | $0.00 | |
|
Pulmonx Corp LUNG
Common Stock
|
2025-03-20 | Sell | 20,000 | $7.85 | 157,000 |
|
Pulmonx Corp LUNG
Common Stock
|
2025-02-20 | Sell | 43,036 | $8.14 | 350,313 |
|
Pulmonx Corp LUNG
Common Stock
|
2025-02-20 | Sell | 12,417 | $8.76 | 108,773 |
|
Pulmonx Corp LUNG
Common Stock
|
2025-01-17 | Sell | 2,221 | $6.50 | 14,436 |
|
Pulmonx Corp LUNG
Common Stock
|
2025-01-16 | Sell | 2,326 | $6.53 | 15,189 |
|
Pulmonx Corp LUNG
Common Stock
|
2024-11-22 | Sell | 20,000 | $6.63 | 132,600 |
|
Pulmonx Corp LUNG
Common Stock
|
2024-10-17 | Sell | 20,000 | $6.52 | 130,400 |
|
Pulmonx Corp LUNG
Common Stock
|
2024-09-12 | Sell | 20,000 | $8.09 | 161,800 |
|
Pulmonx Corp LUNG
Common Stock
|
2024-06-03 | Grant | 15,216 | $0.00 | |
|
Pulmonx Corp LUNG
Common Stock
|
2024-03-01 | Sell | 3,947 | $9.06 | 35,760 |
|
Pulmonx Corp LUNG
Common Stock
|
2024-03-01 | Sell | 1,189 | $9.06 | 10,772 |
|
Pulmonx Corp LUNG
Common Stock
|
2024-03-01 | Sell | 1,818 | $9.06 | 16,471 |
| showing 20 of 95 most recent transactions | |||||